Similar results were obtained concerning the immunofluorescence analysis of Parkin and TOM20 (Fig. 6D, E), which indicate that flubendazole induces DRP1-mediated mitophagy via targeting EVA1A in breast cancer. The gene discussed is EVA1A; the disease is breast carcinoma.